Search
With PharmaDeals you will find: 30276 healthcare and biotech deals
Latest News from Pharma Deals
Dynavax’s Deal Termination with Merck is followed by a New Agreement with GSK
2008-12-17
The US biotech, Dynavax, has become the latest company to enter into an option agreement with GlaxoSmithKline. This comes as a boost to the company following the termination of its agreement with Merck for its most advanced product – the Hepatitis B vaccine, Heplisav.
Pfizer Gains European Rights to Specialist Biologic Product, Xiaflex
2008-12-17
Pfizer has gained European rights to Auxilium Pharmaceuticals’ Xiaflex™ (clostridial collagenase for injection) – a novel, first-in-class, late-stage biologic, for the treatment of Dupuytren's contracture and Peyronie's disease. There is a growing trend for Big Pharma to build up their specialty care product portfolio, illustrated by the multiple offers that Auxilium says it received for Xiaflex.
Teva Invests in Yeast-based Drug Discovery Technology
2008-12-15
Teva has entered into an agreement with Yissum, the Hebrew University of Jerusalem technology transfer company, to finance a yeast-based drug discovery technology developed by Jexys, a Yissum subsidiary. This early investment highlights Teva’s confidence in the technology and supports Teva’s efforts to boost its activity within proprietary drug development.
Biota Focuses on the Future
Interview with Dr Leigh Farrell, VP, Business Development, Biota Holdings.
Latest Deal Making News (RSS)
- 2009-01-02 Valeant Pharmaceuticals completes acquisition of Dow Pharmaceutical Sciences, Inc
- 2009-01-02 Response Genetics Signs Amendment to Its Master Service Agreement With GlaxoSmithKline as Preferred Provider of Genetic Testing Services
- 2009-01-02 Imugene Limited (IMU.AX) and Merial Establish Strategic Alliance
- 2009-01-02 Roche (RHHBY) (JOBS) Purchases Shares in Tender Offer For Memory Pharmaceuticals (MEMY)
- 2008-12-31 Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
- 2008-12-30 Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc
- 2008-12-30 King Completes Acquisition of Alpharma
- 2008-12-30 Synta signs potential $1 billion deal with Roche
- 2008-12-29 Pacgen Terminates Letter of Intent with Medigen
- 2008-12-27 Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
Upcoming Conferences
- 13th Annual Drug Delivery Partnerships
(Jan 21 - 23 2009) - 12th Annual Competitive Intelligence in Pharma
(Jan 27 - 28 2009) - Global Pricing & Reimbursement Congress 2009
(Jan 27 - 28 2009) - 2nd Annual European Life Science CEO Forum For Partnering & Investing
(Feb 3 - 4 2009)
Bookmarks
Bookmark PharmaDeals through one of these social networks.
